EU bars Dextrose tablet maker’s glucose health benefit claims

Organisation: Position: Deadline Date: Location:

The EU’s top court has barred Germany’s Dextro Energy from making claims about the health benefits of glucose contained in its products, which include Dextrose tablets, reports Reuters Health.

Dextro Energy, which was not immediately available for comment on the ruling, had asked the European Commission in 2011 to approve certain health claims about its glucose products, which the EU executive refused. These assertions included glucose supporting normal physical activity and muscle function.

The company appealed this decision, but the EU’s second highest court agreed with the Commission that the health claims were “ambiguous and misleading” as they only presented the benefits and not the risks of increased sugar intake.

Dextro Energy, in a detailed explanation, says on its website: “Pure glucose simply delivers a faster supply of energy to the brain, for an immediate cognitive boost”. But the European Court of Justice confirmed the lower court’s findings, saying Dextro Energy’s application could not be authorised.

EU rules state that if health claims are authorised, they may be used by any food business operator on labels and advertising for its relevant nutrients or food categories.

Reuters Health report

Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.